Babassu aqueous extract (BAE) as an adjuvant for T helper (Th)1-dependent immune responses in mice of a Th2 immune response-prone strain

[1] Carvalho EM(1992)Immunologic markers of clinical evolution in children recently infected with J Infect Dis 165 535-540

[2] Barral A(2003)Recent progress in herpes simplex virus immunobiology and vaccine research Clin Microbiol Rev 16 96-113

[3] Pedral-Sampaio D(2009)Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity J Immunol 183 718-731

[4] Barral-Netto M(2010)Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis BMC Microbiol 10 181-256

[5] Badaró R(2010)Enhancement of immunomodulatory activity by liposome-encapsulated natural phosphodiester bond CpG-DNA in a human B cell line BMB Rep 43 250-496

[6] Rocha H(2004)Vaccine adjuvants: current state and future trends Immunol Cell Biol 82 488-984

[7] Johnson WD(2005)What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery? Braz J Med Biol Res 38 979-118

[8] Koelle D(2002)Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines Expert Rev Vaccines 1 111-248

[9] Corey L(2002)Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Infect Immun 70 240-6117

[10] Almeida AS(2007)The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Vaccine 25 6107-5300

[1] Carvalho EM(1992)Immunologic markers of clinical evolution in children recently infected with J Infect Dis 165 535-540

[2] Barral A(2003)Recent progress in herpes simplex virus immunobiology and vaccine research Clin Microbiol Rev 16 96-113

[3] Pedral-Sampaio D(2009)Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity J Immunol 183 718-731

[4] Barral-Netto M(2010)Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis BMC Microbiol 10 181-256

[5] Badaró R(2010)Enhancement of immunomodulatory activity by liposome-encapsulated natural phosphodiester bond CpG-DNA in a human B cell line BMB Rep 43 250-496

[6] Rocha H(2004)Vaccine adjuvants: current state and future trends Immunol Cell Biol 82 488-984

[7] Johnson WD(2005)What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery? Braz J Med Biol Res 38 979-118

[8] Koelle D(2002)Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines Expert Rev Vaccines 1 111-248

[9] Corey L(2002)Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Infect Immun 70 240-6117

[10] Almeida AS(2007)The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Vaccine 25 6107-5300